BDBM376065 3-(4-methyl-1,3-oxazol-2-yl)- N-(5-methyl-1H,1$#8243;H- 3,1':3',4$#8243;-terpyrazol-5'-yl)-4- (trifluoromethyl)benzamide::US9914736, Compound 61

SMILES Cc1coc(n1)-c1cc(ccc1C(F)(F)F)C(=O)Nc1cc(nn1-c1cc(C)[nH]n1)-c1cn[nH]c1

InChI Key InChIKey=DFMOZKHFXXPBMA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 376065   

TargetHigh affinity nerve growth factor receptor(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM376065(US9914736, Compound 61 | 3-(4-methyl-1,3-oxazol-2-...)
Affinity DataIC50: 3.10nMAssay Description: In this assay, U2OS cells express the human TrkA receptor as a fusion with the weakly complementing fragment of B-galactosidase, which DiscoverX cal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent